BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Drug Development

  Portola Pharmaceuticals, Inc. Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation

  November 3, 2008

   · 

  5 min read
• Drug Development

  Romark Laboratories, L.C. Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008

  November 3, 2008

   · 

  4 min read
• Drug Development

  Medgenics, Inc. Announces Encouraging Preliminary Data For Phase I/II Clinical Trial of EPODURE In Renal Anemia

  November 3, 2008

   · 

  7 min read
• Biotech Beach

  CNS Response Provides Review of an Eating Disorder Poster Delivered at the U.S. Psychiatric and Mental Health Congress

  November 3, 2008

   · 

  1 min read
• BioMidwest

  AtCor Medical Pty Ltd Introduces New Portable Systems for Measuring Central Blood Pressure, Pulse Wave Velocity and Heart Rate Variability

  November 3, 2008

   · 

  1 min read
• Business

  International Drug & Explosives Detection Firm IDenta Corporation, Releases 2008 Year to Date Revenues -- Forecasts Three-Fold Increase in 2009

  November 3, 2008

   · 

  1 min read
• Business

  PHT Corporation Achieves Strong 3rd Quarter Results Leading Electronic Patient Reported Outcomes (ePRO) Market

  November 3, 2008

   · 

  1 min read
• Deals

  Daiichi Sankyo Co Ltd. Acquires Merck Serono’s Cardio-Metabolism Sales Force and Products in Turkey; 20 Employees and the Product Families of Concor and Glucophage Affected

  November 3, 2008

   · 

  3 min read
• Business

  Biolex Therapeutics Adds Two Drug Development Executives to Accelerate Development of Locteron(R) in Hepatitis C

  November 3, 2008

   · 

  1 min read
• FDA

  Cephalon, Inc. Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin’s Lymphoma

  November 3, 2008

   · 

  7 min read